Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

US Patent 12006355 · Granted Jun 11, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the prevention or treatment of cytokine storm2025
Treatment of neurodevelopmental disorders2025
Methods of inhibiting formation of alpha synuclein aggregates2025
Co-crystal of sorafenib derivatives and process for preparation thereof2024
Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (F2024
Methods of improving cell-based therapy2023
Methods of improving cell-based therapy2023
Orally available sEH/PDE4 dual inhibitors2023
Orally available sEH/PDE4 dual inhibitors2023
Methods of improving cancer chemotherapy2022
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) in2022
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) in2022